000 01636 a2200433 4500
005 20250517105221.0
264 0 _c20170726
008 201707s 0 0 eng d
022 _a1872-6240
024 7 _a10.1016/j.brainres.2016.07.026
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWatson, Christopher P
245 0 0 _aThe transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and L-arginine with the human blood-brain barrier in vitro.
_h[electronic resource]
260 _bBrain research
_c10 2016
300 _a232-242 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aArginine
_xanalogs & derivatives
650 0 4 _aBlood-Brain Barrier
_xmetabolism
650 0 4 _aCationic Amino Acid Transporter 1
_xmetabolism
650 0 4 _aCell Line
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aInterferon-gamma
_xpharmacology
650 0 4 _aNitric Oxide
_xmetabolism
650 0 4 _aOrnithine
_xanalogs & derivatives
650 0 4 _aPermeability
650 0 4 _aReactive Oxygen Species
_xmetabolism
650 0 4 _aSucrose
_xmetabolism
650 0 4 _aTumor Necrosis Factor-alpha
_xpharmacology
700 1 _aPazarentzos, Evangelos
700 1 _aFidanboylu, Mehmet
700 1 _aPadilla, Beatriz
700 1 _aBrown, Rachel
700 1 _aThomas, Sarah A
773 0 _tBrain research
_gvol. 1648
_gno. Pt A
_gp. 232-242
856 4 0 _uhttps://doi.org/10.1016/j.brainres.2016.07.026
_zAvailable from publisher's website
999 _c26240829
_d26240829